Literature DB >> 21211785

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Louise C Laurent1, Igor Ulitsky, Ileana Slavin, Ha Tran, Andrew Schork, Robert Morey, Candace Lynch, Julie V Harness, Sunray Lee, Maria J Barrero, Sherman Ku, Marina Martynova, Ruslan Semechkin, Vasiliy Galat, Joel Gottesfeld, Juan Carlos Izpisua Belmonte, Chuck Murry, Hans S Keirstead, Hyun-Sook Park, Uli Schmidt, Andrew L Laslett, Franz-Josef Muller, Caroline M Nievergelt, Ron Shamir, Jeanne F Loring.   

Abstract

Genomic stability is critical for the clinical use of human embryonic and induced pluripotent stem cells. We performed high-resolution SNP (single-nucleotide polymorphism) analysis on 186 pluripotent and 119 nonpluripotent samples. We report a higher frequency of subchromosomal copy number variations in pluripotent samples compared to nonpluripotent samples, with variations enriched in specific genomic regions. The distribution of these variations differed between hESCs and hiPSCs, characterized by large numbers of duplications found in a few hESC samples and moderate numbers of deletions distributed across many hiPSC samples. For hiPSCs, the reprogramming process was associated with deletions of tumor-suppressor genes, whereas time in culture was associated with duplications of oncogenic genes. We also observed duplications that arose during a differentiation protocol. Our results illustrate the dynamic nature of genomic abnormalities in pluripotent stem cells and the need for frequent genomic monitoring to assure phenotypic stability and clinical safety. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21211785      PMCID: PMC3043464          DOI: 10.1016/j.stem.2010.12.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  32 in total

1.  Preserving the genetic integrity of human embryonic stem cells.

Authors:  Maisam M Mitalipova; Raj R Rao; Deborah M Hoyer; Julie A Johnson; Lorraine F Meisner; Karen L Jones; Stephen Dalton; Steven L Stice
Journal:  Nat Biotechnol       Date:  2005-01       Impact factor: 54.908

2.  In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells.

Authors:  M P Imreh; K Gertow; J Cedervall; C Unger; K Holmberg; K Szöke; L Csöregh; G Fried; S Dilber; E Blennow; L Ahrlund-Richter
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

3.  Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors:  Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal:  Nat Biotechnol       Date:  2008-11-23       Impact factor: 54.908

4.  FDA scrutinizes human stem cell therapies.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2008-06       Impact factor: 54.908

5.  Oct4 and its pseudogenes confuse stem cell research.

Authors:  Stefanie Liedtke; Jürgen Enczmann; Simon Waclawczyk; Peter Wernet; Gesine Kögler
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

6.  Specific chromosome change, i(12p), in testicular tumours?

Authors:  N B Atkin; M C Baker
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

7.  Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.

Authors:  Y Midorikawa; S Yamamoto; S Ishikawa; N Kamimura; H Igarashi; H Sugimura; M Makuuchi; H Aburatani
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

8.  Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma.

Authors:  Denitsa K Koynova; Ekaterina S Jordanova; Angel D Milev; Remco Dijkman; Krassimir S Kirov; Draga I Toncheva; Nelleke A Gruis
Journal:  Melanoma Res       Date:  2007-02       Impact factor: 3.599

9.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

10.  Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours.

Authors:  Stine H Kresse; Karoly Szuhai; Ana H Barragan-Polania; Halfdan Rydbeck; Anne-Marie Cleton-Jansen; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  BMC Res Notes       Date:  2010-08-08
View more
  384 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 2.  Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.

Authors:  Claudia Gundacker; Helmut Dolznig; Mario Mikula; Margit Rosner; Oliver Brandau; Markus Hengstschläger
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

Review 3.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

4.  The labyrinth of nuclear reprogramming.

Authors:  Ignacio Sancho-Martinez; Emmanuel Nivet; Juan Carlos Izpisua Belmonte
Journal:  J Mol Cell Biol       Date:  2011-11-16       Impact factor: 6.216

5.  Induced pluripotent stem cell clones reprogrammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences.

Authors:  J Weltner; A Anisimov; K Alitalo; T Otonkoski; R Trokovic
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

6.  Non-viral iPSCs: a safe way for therapy?

Authors:  Weiqi Zhang; Di Guan; Jing Qu; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-04       Impact factor: 14.870

7.  Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.

Authors:  Tea Soon Park; Ludovic Zimmerlin; Elias T Zambidis
Journal:  Cytometry A       Date:  2012-06-26       Impact factor: 4.355

Review 8.  Human induced pluripotent stem cells--from mechanisms to clinical applications.

Authors:  Katharina Drews; Justyna Jozefczuk; Alessandro Prigione; James Adjaye
Journal:  J Mol Med (Berl)       Date:  2012-05-30       Impact factor: 4.599

Review 9.  CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Authors:  Mara Cananzi; Paolo De Coppi
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

10.  Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells.

Authors:  Jieun Lee; Sarah E B Taylor; Piera Smeriglio; Janice Lai; William J Maloney; Fan Yang; Nidhi Bhutani
Journal:  FASEB J       Date:  2015-04-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.